History of psychosis and mania, and outcomes after kidney transplantation - a retrospective study

M. Molnár, James D. Eason, Abduzhappar Gaipov, Manish Talwar, Praveen K. Potukuchi, Kiran Joglekar, A. Remport, Zoltan Mathe, I. Mucsi, M. Novák, Kamyar Kalantar-Zadeh, Csaba P. Kovesdy

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

History of psychosis or mania, if uncontrolled, both represent relative contraindications for kidney transplantation. We examined 3680 US veterans who underwent kidney transplantation. The diagnosis of history of psychosis/mania was based on a validated algorithm. Measured confounders were used to create a propensity score-matched cohort (n = 442). Associations between pretransplantation psychosis/mania and death with functioning graft, all-cause death, graft loss, and rejection were examined in survival models and logistic regression models. Post-transplant medication nonadherence was assessed using proportion of days covered (PDC) for tacrolimus and mycophenolic acid in both groups. The mean ± SD age of the cohort at baseline was 61 ± 11 years, 92% were male, and 66% and 27% of patients were white and African-American, respectively. Compared to patients without history of psychosis/mania, patients with a history of psychosis/mania had similar risk of death with functioning graft [subhazard ratio (SHR) (95% confidence interval (CI)): 0.94(0.42–2.09)], all-cause death [hazard ratio (95% CI): 1.04 (0.51–2.14)], graft loss [SHR (95% CI): 1.07 (0.45–2.57)], and rejection [odds ratio(95% CI): 1.23(0.60–2.53)]. Moreover, there was no difference in immunosuppressive drug PDC in patients with and without history of psychosis/mania (PDC: 76 ± 21% vs. 78 ± 19%, P = 0.529 for tacrolimus; PDC: 78 ± 17% vs. 79 ± 18%, P = 0.666 for mycophenolic acid). After careful selection, pretransplantation psychosis/mania is not associated with adverse outcomes in kidney transplant recipients.

Original languageEnglish
Pages (from-to)554-565
Number of pages12
JournalTransplant International
Volume31
Issue number5
DOIs
Publication statusPublished - May 1 2018

Fingerprint

Bipolar Disorder
Psychotic Disorders
Kidney Transplantation
Retrospective Studies
Confidence Intervals
Mycophenolic Acid
Transplants
Tacrolimus
Cause of Death
Logistic Models
Propensity Score
Medication Adherence
Graft Rejection
Veterans
Immunosuppressive Agents
African Americans
Odds Ratio
Kidney
Survival
Pharmaceutical Preparations

Keywords

  • bipolar disorder
  • kidney transplantation
  • mortality
  • schizophrenia
  • survival

ASJC Scopus subject areas

  • Transplantation

Cite this

Molnár, M., Eason, J. D., Gaipov, A., Talwar, M., Potukuchi, P. K., Joglekar, K., ... Kovesdy, C. P. (2018). History of psychosis and mania, and outcomes after kidney transplantation - a retrospective study. Transplant International, 31(5), 554-565. https://doi.org/10.1111/tri.13127

History of psychosis and mania, and outcomes after kidney transplantation - a retrospective study. / Molnár, M.; Eason, James D.; Gaipov, Abduzhappar; Talwar, Manish; Potukuchi, Praveen K.; Joglekar, Kiran; Remport, A.; Mathe, Zoltan; Mucsi, I.; Novák, M.; Kalantar-Zadeh, Kamyar; Kovesdy, Csaba P.

In: Transplant International, Vol. 31, No. 5, 01.05.2018, p. 554-565.

Research output: Contribution to journalArticle

Molnár, M, Eason, JD, Gaipov, A, Talwar, M, Potukuchi, PK, Joglekar, K, Remport, A, Mathe, Z, Mucsi, I, Novák, M, Kalantar-Zadeh, K & Kovesdy, CP 2018, 'History of psychosis and mania, and outcomes after kidney transplantation - a retrospective study', Transplant International, vol. 31, no. 5, pp. 554-565. https://doi.org/10.1111/tri.13127
Molnár, M. ; Eason, James D. ; Gaipov, Abduzhappar ; Talwar, Manish ; Potukuchi, Praveen K. ; Joglekar, Kiran ; Remport, A. ; Mathe, Zoltan ; Mucsi, I. ; Novák, M. ; Kalantar-Zadeh, Kamyar ; Kovesdy, Csaba P. / History of psychosis and mania, and outcomes after kidney transplantation - a retrospective study. In: Transplant International. 2018 ; Vol. 31, No. 5. pp. 554-565.
@article{596370facd304920a4c7ff3fc264d0a1,
title = "History of psychosis and mania, and outcomes after kidney transplantation - a retrospective study",
abstract = "History of psychosis or mania, if uncontrolled, both represent relative contraindications for kidney transplantation. We examined 3680 US veterans who underwent kidney transplantation. The diagnosis of history of psychosis/mania was based on a validated algorithm. Measured confounders were used to create a propensity score-matched cohort (n = 442). Associations between pretransplantation psychosis/mania and death with functioning graft, all-cause death, graft loss, and rejection were examined in survival models and logistic regression models. Post-transplant medication nonadherence was assessed using proportion of days covered (PDC) for tacrolimus and mycophenolic acid in both groups. The mean ± SD age of the cohort at baseline was 61 ± 11 years, 92{\%} were male, and 66{\%} and 27{\%} of patients were white and African-American, respectively. Compared to patients without history of psychosis/mania, patients with a history of psychosis/mania had similar risk of death with functioning graft [subhazard ratio (SHR) (95{\%} confidence interval (CI)): 0.94(0.42–2.09)], all-cause death [hazard ratio (95{\%} CI): 1.04 (0.51–2.14)], graft loss [SHR (95{\%} CI): 1.07 (0.45–2.57)], and rejection [odds ratio(95{\%} CI): 1.23(0.60–2.53)]. Moreover, there was no difference in immunosuppressive drug PDC in patients with and without history of psychosis/mania (PDC: 76 ± 21{\%} vs. 78 ± 19{\%}, P = 0.529 for tacrolimus; PDC: 78 ± 17{\%} vs. 79 ± 18{\%}, P = 0.666 for mycophenolic acid). After careful selection, pretransplantation psychosis/mania is not associated with adverse outcomes in kidney transplant recipients.",
keywords = "bipolar disorder, kidney transplantation, mortality, schizophrenia, survival",
author = "M. Moln{\'a}r and Eason, {James D.} and Abduzhappar Gaipov and Manish Talwar and Potukuchi, {Praveen K.} and Kiran Joglekar and A. Remport and Zoltan Mathe and I. Mucsi and M. Nov{\'a}k and Kamyar Kalantar-Zadeh and Kovesdy, {Csaba P.}",
year = "2018",
month = "5",
day = "1",
doi = "10.1111/tri.13127",
language = "English",
volume = "31",
pages = "554--565",
journal = "Transplant International",
issn = "0934-0874",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - History of psychosis and mania, and outcomes after kidney transplantation - a retrospective study

AU - Molnár, M.

AU - Eason, James D.

AU - Gaipov, Abduzhappar

AU - Talwar, Manish

AU - Potukuchi, Praveen K.

AU - Joglekar, Kiran

AU - Remport, A.

AU - Mathe, Zoltan

AU - Mucsi, I.

AU - Novák, M.

AU - Kalantar-Zadeh, Kamyar

AU - Kovesdy, Csaba P.

PY - 2018/5/1

Y1 - 2018/5/1

N2 - History of psychosis or mania, if uncontrolled, both represent relative contraindications for kidney transplantation. We examined 3680 US veterans who underwent kidney transplantation. The diagnosis of history of psychosis/mania was based on a validated algorithm. Measured confounders were used to create a propensity score-matched cohort (n = 442). Associations between pretransplantation psychosis/mania and death with functioning graft, all-cause death, graft loss, and rejection were examined in survival models and logistic regression models. Post-transplant medication nonadherence was assessed using proportion of days covered (PDC) for tacrolimus and mycophenolic acid in both groups. The mean ± SD age of the cohort at baseline was 61 ± 11 years, 92% were male, and 66% and 27% of patients were white and African-American, respectively. Compared to patients without history of psychosis/mania, patients with a history of psychosis/mania had similar risk of death with functioning graft [subhazard ratio (SHR) (95% confidence interval (CI)): 0.94(0.42–2.09)], all-cause death [hazard ratio (95% CI): 1.04 (0.51–2.14)], graft loss [SHR (95% CI): 1.07 (0.45–2.57)], and rejection [odds ratio(95% CI): 1.23(0.60–2.53)]. Moreover, there was no difference in immunosuppressive drug PDC in patients with and without history of psychosis/mania (PDC: 76 ± 21% vs. 78 ± 19%, P = 0.529 for tacrolimus; PDC: 78 ± 17% vs. 79 ± 18%, P = 0.666 for mycophenolic acid). After careful selection, pretransplantation psychosis/mania is not associated with adverse outcomes in kidney transplant recipients.

AB - History of psychosis or mania, if uncontrolled, both represent relative contraindications for kidney transplantation. We examined 3680 US veterans who underwent kidney transplantation. The diagnosis of history of psychosis/mania was based on a validated algorithm. Measured confounders were used to create a propensity score-matched cohort (n = 442). Associations between pretransplantation psychosis/mania and death with functioning graft, all-cause death, graft loss, and rejection were examined in survival models and logistic regression models. Post-transplant medication nonadherence was assessed using proportion of days covered (PDC) for tacrolimus and mycophenolic acid in both groups. The mean ± SD age of the cohort at baseline was 61 ± 11 years, 92% were male, and 66% and 27% of patients were white and African-American, respectively. Compared to patients without history of psychosis/mania, patients with a history of psychosis/mania had similar risk of death with functioning graft [subhazard ratio (SHR) (95% confidence interval (CI)): 0.94(0.42–2.09)], all-cause death [hazard ratio (95% CI): 1.04 (0.51–2.14)], graft loss [SHR (95% CI): 1.07 (0.45–2.57)], and rejection [odds ratio(95% CI): 1.23(0.60–2.53)]. Moreover, there was no difference in immunosuppressive drug PDC in patients with and without history of psychosis/mania (PDC: 76 ± 21% vs. 78 ± 19%, P = 0.529 for tacrolimus; PDC: 78 ± 17% vs. 79 ± 18%, P = 0.666 for mycophenolic acid). After careful selection, pretransplantation psychosis/mania is not associated with adverse outcomes in kidney transplant recipients.

KW - bipolar disorder

KW - kidney transplantation

KW - mortality

KW - schizophrenia

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=85045516722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045516722&partnerID=8YFLogxK

U2 - 10.1111/tri.13127

DO - 10.1111/tri.13127

M3 - Article

C2 - 29405487

AN - SCOPUS:85045516722

VL - 31

SP - 554

EP - 565

JO - Transplant International

JF - Transplant International

SN - 0934-0874

IS - 5

ER -